---
title: "Siemens Healthcare Diagnostics Ltd(merged) (506559) — Share Price, Financials & Analysis"
symbol: "506559"
company: "Siemens Healthcare Diagnostics Ltd(merged)"
canonical: "https://tapetide.com/stocks/506559"
isin: "INE195D01014"
bse_code: "506559"
generated_at: "2026-10-13T11:01:15.563Z"
---

# Siemens Healthcare Diagnostics Ltd(merged) (506559)

Canonical page: https://tapetide.com/stocks/506559

## Company

- **BSE Code:** 506559
- **ISIN:** INE195D01014
- **Stock Type:** DELISTED
- **Face Value:** ₹10
- **F&O Eligible:** No

## Latest Price

## Key Insights

### Weaknesses

- Company might be capitalizing the interest cost

## Growth Rates

| Metric | 1Y | 3Y |
| --- | --- | --- |
| net income growth | 82% | 39% |
| revenue growth | 5% | 49% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 9.03 | 9.35 | 12.47 | 13.83 | 17.97 | 13.4 |
| Expenses | 8.51 | 8.38 | 12.18 | 12.97 | 15.84 | 11.31 |
| Operating Profit | 0.52 | 0.97 | 0.29 | 0.86 | 2.13 | 2.09 |
| OPM % | 5.76 | 10.37 | 2.33 | 6.22 | 11.85 | 15.6 |
| Other Income | 0 | 0 | 0.35 | 0.01 | 0.03 | 0.01 |
| Interest | 0.13 | 0.19 | 0.22 | 0.12 | 0.23 | 0.23 |
| Depreciation | 0.14 | 0.11 | 0.29 | 0.26 | 0.38 | 0.43 |
| Profit before tax | 0.25 | 0.67 | 0.13 | 0.49 | 1.55 | 1.44 |
| Tax % | 28 | 40.3 | -30.77 | 20.41 | 29.03 | 27.08 |
| Net Profit | 0.18 | 0.41 | 0.16 | 0.39 | 1.1 | 1.06 |
| EPS in Rs | 28.44 | 2.22 | 0.87 | 1.55 | 4.36 | 4.2 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2005 | Dec 2006 | Sep 2007 9m | Sep 2008 | Sep 2009 | Sep 2010 |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 67 | 73 | 53 | 101 | 167 | 175 |
| Expenses | 55 | 86 | 45 | 88 | 139 | 140 |
| Operating Profit | 12 | -13 | 8 | 13 | 28 | 35 |
| OPM % | 18 | -18 | 14 | 13 | 17 | 20 |
| Other Income | 2 | 53 | 2 | -7 | 2 | 7 |
| Interest | 0 | 0 | 0 | 0 | 1 | 3 |
| Depreciation | 4 | 5 | 4 | 9 | 20 | 24 |
| Profit before tax | 10 | 35 | 6 | -3 | 9 | 15 |
| Tax % | 37 | 25 | 32 | -28 | 41 | 37 |
| Net Profit | 6 | 26 | 4 | -2 | 5 | 10 |
| Dividend Payout % | 21 | 63 | 25 | -7 | 30 | 28 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2005 | Dec 2006 | Sep 2007 | Sep 2008 | Sep 2009 | Sep 2010 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 2 | 2 | 2 | 2 | 2 | 2 |
| Reserves | 36 | 44 | 46 | 44 | 47 | 54 |
| Borrowings | 3 | 3 | 0 | 0 | 40 | 40 |
| Other Liabilities | 21 | 42 | 15 | 86 | 106 | 70 |
| Total Liabilities | 61 | 90 | 62 | 131 | 195 | 166 |
| Fixed Assets | 14 | 12 | 16 | 52 | 66 | 63 |
| CWIP | 0 | 0 | 0 | 0 | 1 | 0 |
| Investments | 16 | 19 | 14 | 7 | 0 | 0 |
| Other Assets | 32 | 58 | 32 | 72 | 128 | 102 |
| Total Assets | 61 | 90 | 62 | 131 | 195 | 166 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2005 | Dec 2006 | Sep 2007 | Sep 2008 | Sep 2009 | Sep 2010 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 10 | 10 | 0 | 36 | 57 | 12 |
| Cash from Investing Activity | -8 | 15 | -2 | -37 | -70 | -21 |
| Cash from Financing Activity | -2 | -3 | -17 | -1 | 39 | -4 |
| Net Cash Flow | 1 | 22 | -18 | -2 | 26 | -13 |
| Free Cash Flow | 4 | 27 | -7 | -7 | 23 | -9 |
| CFO/OP | 121 | -99 | 97 | 304 | 226 | 53 |

### Ratios

| Item | Dec 2005 | Dec 2006 | Sep 2007 | Sep 2008 | Sep 2009 | Sep 2010 |
| --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 52 | 50 | 91 | 124 | 95 | 83 |
| Inventory Days | 57 | 31 | 83 | 139 | 146 | 116 |
| Days Payable | 32 | 24 | 51 | 476 | 348 | 235 |
| Cash Conversion Cycle | 77 | 56 | 122 | -213 | -106 | -36 |
| Working Capital Days | 42 | -46 | 63 | -77 | -36 | 6 |
| ROCE % | — | 22 | 12 | 11 | 15 | 20 |

## Shareholding Pattern

### annual

| Category | Mar 2024 | Mar 2025 | Sep 2025 |
| --- | --- | --- | --- |
| Promoters | 98.63% | 72.05% | 72.05% |
| Public | 1.37% | 27.96% | 27.95% |
| No. of Shareholders | 7 | 117 | 129 |

### Quarterly

| Category | Mar 2024 | Apr 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
| --- | --- | --- | --- | --- | --- |
| Promoters | 98.63% | 72.05% | 72.05% | 72.05% | 72.05% |
| FIIs | 0% | 6.34% | 0% | 0% | 0% |
| DIIs | 0% | 6.34% | 0% | 0% | 0% |
| Public | 1.37% | 15.27% | 27.95% | 27.96% | 27.95% |
| No. of Shareholders | 7 | 161 | 95 | 117 | 129 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 7 / 7 / 5

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 523.99 | Sell |
| EMA (10) | 518.43 | Sell |
| SMA (20) | 520.81 | Sell |
| EMA (20) | 512.96 | Buy |
| SMA (50) | 480.85 | Buy |
| EMA (50) | 495.9 | Buy |
| SMA (100) | 484.18 | Buy |
| EMA (100) | 490.88 | Buy |
| SMA (200) | 499.82 | Buy |
| EMA (200) | 503.99 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 53.79 | Neutral |
| MACD (12,26,9) | 10.01 | Sell |
| Stochastic (14,3,3) | 42.16 | Neutral |
| ADX (14) | 21.32 | Neutral |
| Williams %R (14) | -57.21 | Neutral |
| ATR (14) | 19.27 | High Volatility |
| ROC (12) | -1.21 | Sell |
| Stoch RSI (14) | 26.16 | Neutral |
| UO (7,14,28) | 52.64 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 2026-02-18 | [EGM To Be Held On March 12, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a5192c50-1633-4d25-a4b4-dfa69dd25682.pdf) |
| 2026-02-18 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8141940d-8783-4603-ac97-322f7c791a4e.pdf) |
| 2026-02-18 | [Closure of Trading Window](https://www.bseindia.com/xml-data/corpfiling/AttachHis/993d7138-2a2e-4eae-b55c-136331d695c3.pdf) |
| 2026-01-13 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2dec1b80-5b76-4b0b-8e50-2f52e8c64b00.pdf) |
| 2025-11-13 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f3c7a3a7-df3e-41a5-b59d-721b28a49a35.pdf) |
| 2025-11-13 | [Financial Results - September 30, 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/78228797-07b5-4c70-92e5-3763da2e1977.pdf) |
| 2025-11-05 | [Board Meeting Intimation for Board Meeting Intimation](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3977204a-866d-4adf-9f40-8338df4341e5.pdf) |
| 2025-10-15 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018](https://www.bseindia.com/xml-data/corpfiling/AttachHis/910fa861-8c4c-468b-a5d6-2faa52a1ffac.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| 2025 | [Financial Year 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/34813b2a-1c00-418b-b5bf-6d261a62a33c.pdf) |
| 2024 | [Financial Year 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/65bf7392-dc44-48e3-963a-2d57bf5c2f34.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T11:01:15.563Z.